These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 9819568

  • 21. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.
    Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H.
    Nature; 1992 Oct 01; 359(6394):423-6. PubMed ID: 1406955
    [Abstract] [Full Text] [Related]

  • 22. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
    Delgado MD, Lerga A, Cañelles M, Gómez-Casares MT, León J.
    Oncogene; 1995 Apr 20; 10(8):1659-65. PubMed ID: 7731722
    [Abstract] [Full Text] [Related]

  • 23. Sin3 corepressor function in Myc-induced transcription and transformation.
    Harper SE, Qiu Y, Sharp PA.
    Proc Natl Acad Sci U S A; 1996 Aug 06; 93(16):8536-40. PubMed ID: 8710905
    [Abstract] [Full Text] [Related]

  • 24. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP, Sonenshein GE.
    Oncogene; 2001 Mar 29; 20(14):1688-702. PubMed ID: 11313917
    [Abstract] [Full Text] [Related]

  • 25. Lack of transcriptional repression by max homodimers.
    Yin X, Grove L, Prochownik EV.
    Oncogene; 1998 May 29; 16(20):2629-37. PubMed ID: 9632139
    [Abstract] [Full Text] [Related]

  • 26. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
    Koskinen PJ, Ayer DE, Eisenman RN.
    Cell Growth Differ; 1995 Jun 29; 6(6):623-9. PubMed ID: 7669717
    [Abstract] [Full Text] [Related]

  • 27. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis.
    Hurlin PJ, Foley KP, Ayer DE, Eisenman RN, Hanahan D, Arbeit JM.
    Oncogene; 1995 Dec 21; 11(12):2487-501. PubMed ID: 8545105
    [Abstract] [Full Text] [Related]

  • 28. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.
    Lahoz EG, Xu L, Schreiber-Agus N, DePinho RA.
    Proc Natl Acad Sci U S A; 1994 Jun 07; 91(12):5503-7. PubMed ID: 8202517
    [Abstract] [Full Text] [Related]

  • 29. Function of the c-Myc oncogenic transcription factor.
    Dang CV, Resar LM, Emison E, Kim S, Li Q, Prescott JE, Wonsey D, Zeller K.
    Exp Cell Res; 1999 Nov 25; 253(1):63-77. PubMed ID: 10579912
    [Abstract] [Full Text] [Related]

  • 30. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X, Giap C, Lazo JS, Prochownik EV.
    Oncogene; 2003 Sep 18; 22(40):6151-9. PubMed ID: 13679853
    [Abstract] [Full Text] [Related]

  • 31. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH, Fisher F, Clark W, Jayaraman PS, Goding CR, Gillespie DA.
    Oncogene; 1993 Jul 18; 8(7):1849-55. PubMed ID: 8510929
    [Abstract] [Full Text] [Related]

  • 32. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.
    Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Lüscher B.
    Genes Dev; 2001 Aug 15; 15(16):2042-7. PubMed ID: 11511535
    [Abstract] [Full Text] [Related]

  • 33. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3.
    Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI, DePinho RA.
    Cell; 1995 Mar 10; 80(5):777-86. PubMed ID: 7889571
    [Abstract] [Full Text] [Related]

  • 34. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.
    Yin XY, Gupta K, Han WP, Levitan ES, Prochownik EV.
    Oncogene; 1999 Nov 18; 18(48):6621-34. PubMed ID: 10597267
    [Abstract] [Full Text] [Related]

  • 35. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
    Vervoorts J, Lüscher B.
    Biol Chem; 1999 Sep 18; 380(9):1121-6. PubMed ID: 10543451
    [Abstract] [Full Text] [Related]

  • 36. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
    Hurlin PJ, Quéva C, Koskinen PJ, Steingrímsson E, Ayer DE, Copeland NG, Jenkins NA, Eisenman RN.
    EMBO J; 1995 Nov 15; 14(22):5646-59. PubMed ID: 8521822
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. New Myc-interacting proteins: a second Myc network emerges.
    Sakamuro D, Prendergast GC.
    Oncogene; 1999 May 13; 18(19):2942-54. PubMed ID: 10378691
    [Abstract] [Full Text] [Related]

  • 39. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2.
    Kim MK, Carroll WL.
    Cancer; 2004 Nov 01; 101(9):2106-15. PubMed ID: 15382088
    [Abstract] [Full Text] [Related]

  • 40. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R, Chen JM, Huard S, Wang E.
    J Cell Biochem; 2005 Dec 01; 96(5):1071-85. PubMed ID: 16167342
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.